(Q46696565)
Statements
1 reference
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane (English)
1 reference
1 reference
Kathy D Miller
1 reference
Hope S Rugo
1 reference
Harold J Burstein
1 reference
Anthony D Elias
1 reference
Melody A Cobleigh
1 reference
Peter D Eisenberg
1 reference
Mary Lehman
1 reference
Bonne J Adams
1 reference
Carlo L Bello
1 reference
Samuel E DePrimo
1 reference
Charles M Baum
1 reference
17 March 2008
1 reference
1 reference
26
1 reference
1810-1816
1 reference
11
1 reference
Identifiers
1 reference
1 reference